Preprint / Version 1

Considering Biological Sex in The Development of Dementia

##article.authors##

  • Hoa-Yen Trinh Polygence

DOI:

https://doi.org/10.58445/rars.1786

Keywords:

Dementia, cognitive disease, geriatric

Abstract

Dementia is a neurological, cognitive disease characterized by a patient’s impaired memory and judgment, often seen during the geriatric stages of life. It is estimated that close to 10.7% of people worldwide over the age of 65 have some form of diagnosed dementia. This large percentage creates undue financial and caretaking burdens on family members and heavily impacts healthcare systems. While a cure for dementia is not known, researching this condition paves the way for treatments that could help millions of families. However, for these treatments to be effective, one should consider demographic information, such as biological sex, as a key variable in their studies. The correlation of demographic differences to the development of dementia has yet to be thoroughly studied. To investigate potential sex differences in dementia-related cognitive decline, we used data from The Aging, Dementia, and TBI Study from the Allen Institute for Brain Science that included a variety of patient cognitive assessments—such as the Braak and the NIA-Reagan criteria. Our results indicate a significant correlation between biological sex and the severity of neurodegeneration. Our findings suggest that sex as a biological variable should be given deep consideration when assessing the prognosis of neurodegenerative disorders in human patient populations.

References

CDC. “What Is Dementia?” Centers for Disease Control and Prevention, 5 Apr. 2019, www.cdc.gov/aging/dementia/index.html.

National Institute of Neurological Disorders and Stroke. “Huntington’s Disease.” National Institute of Neurological Disorders and Stroke, 25 July 2022, www.ninds.nih.gov/health-information/disorders/huntingtons-disease.

National Institute on Aging. “Vascular Dementia: Causes, Symptoms, and Treatments.” National Institute on Aging, 1 Nov. 2021, www.nia.nih.gov/health/vascular-dementia/vascular-dementia-causes-symptoms-and-treatments.

National Institute on Aging. “Understanding Different Types of Dementia.” National Institute on Aging, 2024, www.nia.nih.gov/health/alzheimers-and-dementia/understanding-different-types-dementia.

National Health Service. “What Are the Treatments for Dementia?” NHS, 18 Aug. 2023, www.nhs.uk/conditions/dementia/about-dementia/treatment/.

Li, Rena, and Meharvan Singh. “Sex Differences in Cognitive Impairment and Alzheimer’s Disease.” Frontiers in Neuroendocrinology, vol. 35, no. 3, Aug. 2014, pp. 385–403, https://doi.org/10.1016/j.yfrne.2014.01.002.

Alzheimer's Society. “Why Is Dementia Different for Women? | Alzheimer’s Society.” Www.alzheimers.org.uk, 8 Mar. 2023, www.alzheimers.org.uk/blog/why-dementia-different-women#:~:text=Women%20have%20a%20greater%20risk.

“Data Download :: Allen Brain Atlas: Aging, Dementia and TBI Study.” Aging.brain-Map.org, 2004, aging.brain-map.org/download/index.

Newell, Kathy L., et al. “Application of the National Institute on Aging (NIA)-Reagan Institute Criteria for the Neuropathological Diagnosis of Alzheimer Disease.” Journal of Neuropathology and Experimental Neurology, vol. 58, no. 11, Nov. 1999, pp. 1147–1155, https://doi.org/10.1097/00005072-199911000-00004. Accessed 23 Mar. 2021.

Malek-Ahmadi, Michael, et al. “Braak Stage, Cerebral Amyloid Angiopathy, and Cognitive Decline in Early Alzheimer’s Disease.” Journal of Alzheimer’s Disease, vol. 74, no. 1, 10 Mar. 2020, pp. 189–197, https://doi.org/10.3233/jad-191151. Accessed 1 July 2020.

Wadhwa, Raoul R., and Raghavendra Marappa-Ganeshan. “T Test.” PubMed, StatPearls Publishing, 2023, www.ncbi.nlm.nih.gov/books/NBK553048/.

Shwartz, Michael. “Alzheimer Disease | Definition, Causes, Symptoms, & Treatment | Britannica.” Www.britannica.com, 29 Apr. 2024, www.britannica.com/science/Alzheimer-disease#ref107060.

Rocha Cabrero, Franklyn, and Elizabeth H. Morrison. “Lewy Bodies.” PubMed, StatPearls Publishing, 2020, www.ncbi.nlm.nih.gov/books/NBK536956/.

Beach, Thomas G., et al. “Evaluation of α-Synuclein Immunohistochemical Methods Used by Invited Experts.” Acta Neuropathologica, vol. 116, no. 3, 15 July 2008, pp. 277–288, www.ncbi.nlm.nih.gov/pmc/articles/PMC2708176/, https://doi.org/10.1007/s00401-008-0409-8.

World Health Organization. “Dementia.” Www.who.int, World Health Organization, 15 Mar. 2023, www.who.int/news-room/fact-sheets/detail/dementia#:~:text=Key%20facts.

Bennett, D. A., et al. “Neuropathology of Older Persons without Cognitive Impairment from Two Community-Based Studies.” Neurology, vol. 66, no. 12, 26 June 2006, pp. 1837–1844, https://doi.org/10.1212/01.wnl.0000219668.47116.e6.

“What Happens to the Brain in Alzheimer’s Disease?” National Institute on Aging, 19 Jan. 2024, www.nia.nih.gov/health/alzheimers-causes-and-risk-factors/what-happens-brain-alzheimers-disease#:~:text=Neurofibrillary%20tangles%20are%20abnormal%20accumulations.

Downloads

Posted

2024-10-18